產(chǎn)品詳情
簡單介紹：
Anti-BRWD3抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-BRWD3抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-BRWD3
Cat. Number:
Anti-BRWD3抗體KL-11811R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Members of the WD repeat protein family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis and gene regulation. BRWD3 (bromodomain and WD repeat-containing protein 3) is a 1,802 amino acid protein expressed in fetal liver and most ***** tissues. Existing as five Anti-BRWD3抗體alternatively spliced isoforms, BRWD3 contains two bromo domains, nine WD repeats and is thought to play a role in transcription by modifying chromatin. Mutations in the gene encoding BRWD3 are the cause of mental retardation X-linked type 93 (MRX93), which is also known as mental retardation X-linked with macrocephaly (XLMR). MRX93 is characterized by mild intellectual disability, macrocephaly, a prominent forehead and large cupped ears.
Also known as:
BRODL; Bromo domainAnti-BRWD3抗體 containing protein disrupted in leukemia; Bromodomain and WD repeat domain containing 3; Novel WD repeat domain protein; BRWD3_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BRWD3.
●
Predicted Molecular Weight: 203kDa.
Storage:
Shipped at 4℃, Store Anti-BRWD3抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-BRWD3抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-BRWD3抗體dilutions must be determined by the end user.
kl637Hu01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl637Mu01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl637Ra01 氨基己糖苷酶Bβ(HEXβ)多克隆抗體 Polyclonal Antibody to Hexosaminidase B Beta (HEXb)
kl638Bo01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Hu01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Mu01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl638Ra01 內(nèi)脂素(VF)多克隆抗體 Polyclonal Antibody to Visfatin (VF)
kl642Ra01 果糖二磷酸醛縮酶A(ALDOA)多克隆抗體 Polyclonal Antibody to Aldolase A, Fructose Bisphosphate (ALDOA)
kl644Hu01 CCAAT增強(qiáng)子結(jié)合蛋白α(CEBPα)多克隆抗體 Polyclonal Antibody to CCAAT/Enhancer Binding Protein Alpha (CEBPa)
kl645Hu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl645Mu01 晚期糖基化終末產(chǎn)物受體(AGER)多克隆抗體 Polyclonal Antibody to Advanced Glycosylation End Product Specific Receptor (AGER)
kl646Hu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Mu01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl646Ra01 骨形成蛋白6(BMP6)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
kl647Hu01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
kl647Ra01 Smad同源物1(Smad1)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 1 (Smad1)
kl648Hu01 Smad同源物7(Smad7)多克隆抗體 Polyclonal Antibody to Mothers Against Decapentaplegic Homolog 7 (Smad7)
